Hepatitis

Taking a de-centralized approach to cure the Hepatitis C epidemic

https://pharmaphorum.com/partner-content/taking-a-de-centralized-approach-to-cure-the-hepatitis-c-epidemic/

Gilead preps filing for hepatitis D therapy Hepcludex in US

https://pharmaphorum.com/news/gilead-preps-filing-for-hepatitis-d-therapy-hepcludex-in-us/

Hepatitis drug could be tested against COVID-19 in India

https://pharmaphorum.com/news/hepatitis-drug-interferon-could-be-tested-against-covid-19-in-india/

AbbVie sues NHS over hep C drug procurement scheme

https://pharmaphorum.com/news/abbvie-sues-nhs-over-hep-c-drug-procurement-scheme/

Hepatitis drug wins award for cure rate and efficacy

https://pharmaphorum.com/news/hepatitis-drug-wins-award/

US judge overturns Gilead $2.54bn patent infringement ruling

https://pharmaphorum.com/news-market-access/us-judge-overturns-record-2-54bn-hepatitis-c-drug-ruling/

NICE recommends MSD’s hep C pill

https://pharmaphorum.com/news/nice-recommends-msds-hep-c-pill/

After 2015’s ‘breakthrough’ year for pharma approvals, will 2016 see a dip?

https://pharmaphorum.com/views-and-analysis/2015-breakthrough-year-pharma-approvals-will-2016-see-dip/

Move to eradicate viral hepatitis

https://pharmaphorum.com/views-and-analysis/move-eradicate-viral-hepatitis/

1 2

Close in 10 seconds

Pharmaphorum.com

Search